News

MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours

AUSTIN, Texas, October 21, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today published a white paper showing that its LensAI™ immunogenicity screening ran across an entire public antibody database of 890,634 sequences in 4 hours and 41 minutes on Amazon EC2 Hpc8a instances powered by 5th Gen AMD EPYC™ processors, delivering up to 43% lower cost per sequence than a comparable Intel configuration running identical code.

Yahoo·08:01HYFT

MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies

BOSTON, October 14, 2026--MindWalk Holdings Corp. (NASDAQ: HYFT) ("MindWalk" or the "Company"), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the Company’s pipeline advances toward preclinical efficacy studies. Zachary Maben, PhD, joins as Director, Antigen Discovery & Protein Engineering, from Arbor Biotechnologies and previously Pfizer. Joanne Lim, PhD, joins as Director, Preclinical Development, from Orum Therapeu

Yahoo·08:01HYFT

MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function

AUSTIN, Texas, October 06, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today outlined why the ontology layer now being built across enterprise AI does not reach biological function, and why life sciences requires a biological context layer of its own. ReefIQ™, MindWalk's biological context layer for life sciences, supplies what a horizontal ontology cannot: a governed, model-agnostic representation of what biology does, available from the first day of a de

Yahoo·08:46HYFT

AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

Towards Healthcare projects that the global AI in drug discovery market will grow from $19.89 billion in 2025 to $160.49 billion by 2035, a compound annual growth rate of 23.22%. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), AbCellera Biologics Inc. (NASDAQ: ABCL), Eli Lilly and Company (NYSE: LLY), Twist Bioscience Corporation (NASDAQ: TWST) and Tempus AI, Inc. (NASDAQ: TEM).

Yahoo·12:11HYFT

MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director

AUSTIN, Texas, October 01, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced the appointment of Kim Remizowski to its Board of Directors as an independent director, effective September 29, 2026. Mr. Remizowski will serve on the Audit Committee and the Compensation, Nomination and Governance Committee. The Board has determined that he qualifies as an independent director under Nasdaq listing rules and as an audit committee financial expert under a

Yahoo·08:46HYFT

What Is Advanced Micro Devices (AMD) Proving In Edge AI And Life Sciences?

Advanced Micro Devices (NasdaqGS:AMD) and Advantech announced a collaboration to accelerate Edge AI workloads using AMD embedded and GPU platforms. MindWalk has moved OpenFold3 into production on AMD Instinct GPUs, supported by inference microservices for life sciences workflows. The Advantech alliance focuses on scalable, partner-led Edge AI solutions, while MindWalk highlights regulated, production-grade scientific use cases on AMD hardware. The Advantech Edge AI work and MindWalk...

Yahoo·02:12HYFT

MindWalk (HYFT) Is Pivoting to Recurring AI Revenue. Can ReefIQ Offset Widening Losses?

Commercial launch of ReefIQ data platform marks a strategic pivot for MindWalk Holdings Corp. (NASDAQ:HYFT). In its first quarter FY27 report, the company also highlighted its transition toward platform-based recurring revenues. It posted C$3.8 million in revenue, up 21.3% compared to the same period last year. Gross profit of C$2.2 million represented a 47.1% year-over-year […]

Yahoo·11:26HYFT

Advanced Micro Devices (AMD) Is Up 24.7% After Expanding Its Role In Regulated AI Infrastructure – Has The Bull Case Changed?

Advanced Micro Devices has recently been at the center of a series of AI-focused developments, from powering MindWalk’s OpenFold3 life-sciences workloads on Instinct MI325X GPUs to expanding ecosystem collaborations across edge AI, quantum-classical integration, and agentic AI security and infrastructure. Together, these partnerships and deployments highlight AMD’s role not just as a chip supplier but as a foundational compute layer for regulated, production-grade AI systems spanning data...

Yahoo·18:18HYFT

MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine

AUSTIN, Texas, September 21, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced results from a production deployment of the open-source OpenFold3 structure prediction model, run with engineering partners AMD and Vultr on Vultr Kubernetes Engine and Vultr Cloud GPU powered by AMD Instinct™ MI325X GPUs and delivered through AMD Inference Microservices (AIM). It also served as an independent validation of AIM for OpenFold3 in a production life-scienc

Yahoo·08:46

MindWalk Holdings Corp (HYFT) (Q1 2027) Earnings Call Highlights: Revenue Climbs 21% as ReefIQ ...

MindWalk Holdings Corp (HYFT) posts a fifth straight quarter of revenue growth with gross margin expanding to 59%, while investing heavily in the commercial rollout of its ReefIQ data platform.

Yahoo·15:00HYFT

MindWalk (HYFT) Q1 2027 Earnings Call Transcript

ReefIQ launch drives 21% revenue growth amid strategic shift to recurring platform partnerships.

Yahoo·10:01HYFT

MindWalk Holdings Corp. Q1 2027 Earnings Call Summary

Moby summary of MindWalk Holdings Corp.'s Q1 2027 earnings call

Yahoo·08:30HYFT

MindWalk Holdings (NASDAQ:HYFT) Falls After Q1 Revenue Miss and Wider Loss

Mindwalk Holdings (HYFT) Q1 revenue misses estimates; shares fall after hours despite gross margin rising to 58.6% and 21% revenue growth.

ChartMill·19:20HYFT

MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates

MindWalk Holdings Corp. (HYFT) delivered earnings and revenue surprises of -80.00% and -15.48%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo·18:05HYFT

MindWalk Q1 Earnings Call Highlights

MindWalk (NASDAQ:HYFT) reported first-quarter fiscal 2027 revenue of CAD 3.8 million, up 21% from CAD 3.2 million a year earlier, as the company continued investing in commercialization of its ReefIQ biological-data platform and expanded its drug discovery partnership model. Gross margin increased

MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027

AUSTIN, Texas, September 14, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for its fiscal 2027 first quarter ended July 31, 2026. The quarter marked the commercial launch of ReefIQ™, MindWalk's data platform, and the start of its shift toward recurring, platform-based revenue.

Yahoo·16:56HYFT

MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript

MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call September 14, 2026 5:00 PM EDTCompany ParticipantsJennifer Bath - CEO, President & Non-Independent...

SeekingAlpha·15:41HYFT

MindWalk Enters Binding Commitment With Sanabil For Senior Unsecured Revolving Credit Facility Of Up To $30M

The facility is intended to support MindWalk’s biologics programs, commercial expansion, working capital, and general corporate purposes. The facility carries a fixed annual interest rate of 7.00%, accruing only on

Benzinga·04:51HYFT

MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

AUSTIN, Texas, September 10, 2026--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it is participating in the H.C. Wainwright 28th Annual Global Investment Conference, held September 14 - 16, 2026 at the Lotte New York Palace Hotel in New York, where a pre-recorded fireside chat with Chief Executive Officer Dr. Jennifer Bath is available to registered attendees on demand.

Yahoo·08:34HYFT

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026

AUSTIN, Texas, September 08, 2026--MindWalk Holdings Corp. ("MindWalk" or the "Company") (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for the first quarter of fiscal year 2027 and host a conference call on Monday, September 14, 2026, at 5:00 p.m. Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session.

Yahoo·08:30HYFT

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug discovery market at approximately $1.71 billion in 2024 and projects it will reach roughly $8.52 billion by 2030, a compound annual growth rate of about 30.58%. That is a market compounding at more than double the rate of most enterprise software categories, and it is being spent inside an industry that already inves

Yahoo·08:55